Humana AB (publ) (STO:HUM)
Sweden · Delayed Price · Currency is SEK | Market Cap | 2.94B +66.3% |
| Revenue (ttm) | 10.04B -3.4% |
| Net Income | 175.00M -17.8% |
| EPS | 3.61 -13.1% |
| Shares Out | 47.52M |
| PE Ratio | 17.15 |
| Forward PE | 10.51 |
| Dividend | 1.35 (2.18%) |
| Ex-Dividend Date | Jun 2, 2026 |
| Volume | 53,177 |
| Open | 62.90 |
| Previous Close | 61.20 |
| Day's Range | 60.80 - 62.90 |
| 52-Week Range | 35.50 - 67.60 |
| Beta | 0.05 |
| Analysts | Strong Sell |
| Price Target | 68.50 (+10.66%) |
| Earnings Date | Jul 17, 2026 |
About Humana AB
Humana AB (publ) provides individual and family care services for children and adults in Sweden, Finland, Norway, and Denmark. The company operates through three segments: Sweden, Finland, and Norway. It provides care and treatment for psychosocial disorders, mental illness, and functional impairment; residential care homes; family care services; short-term, short term housing, day care, and special service housing; outpatient care; assisted living homes; and specially adapted housing for individuals with functional impairments. The company als... [Read more]
Financial Performance
In 2025, Humana AB's revenue was 10.02 billion, a decrease of -2.72% compared to the previous year's 10.30 billion. Earnings were 236.00 million, an increase of 63.89%.
Financial StatementsAnalyst Summary
According to one analyst, the rating for HUM stock is "Strong Sell" and the 12-month stock price target is kr 68.50.
News
Kaskela Law Firm Announces Investigation of Humana Inc. (HUM) and Encourages Long-Term HUM Shareholders to Contact the Firm
PHILADELPHIA--(BUSINESS WIRE)--Investor litigation firm Kaskela Law announces that it is investigating Humana Inc. (NYSE: HUM) (“Humana”) on behalf of the company's long-term investors. Click here for...
Humana Inc (HUM) Stock Up 3.5% but GF Value Says Overvalued -- GF Score: 87/100
Humana Inc (HUM) Stock Up 3.5% but GF Value Says Overvalued -- GF Score: 87/100
Humana AB Earnings Call Transcript: Q2 2026
Adjusted operating profit rose 6% year-over-year, with margin improvements in Sweden and a robust growth pipeline, especially in Finland and Sweden. Margin pressures persist in personal assistance and Norway, but efficiency programs and acquisitions support a positive outlook.
Humana AB Quarterly report: Q2 2026
Humana AB has published its Q2 2026 quarterly earnings report on July 17, 2026.
Humana AB Slides: Q2 2026
Humana AB has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 17, 2026.
A Look at Humana Inc (HUM) After 5.2% Decline -- GF Value $367.67 vs Price $386.48
A Look at Humana Inc (HUM) After 5.2% Decline -- GF Value $367.67 vs Price $386.48
UnitedHealth Earnings Crush Estimates and Give These Stocks a Boost
The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.
A Look at Humana Inc (HUM) After 3.5% Gain -- GF Value $367.01 vs Price $406.00
A Look at Humana Inc (HUM) After 3.5% Gain -- GF Value $367.01 vs Price $406.00
Humana (HUM) Upgraded to Overweight by Wells Fargo, Price Target Raised to $502
Humana (HUM) Upgraded to Overweight by Wells Fargo, Price Target Raised to $502
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
Humana Inc (HUM) Stock Down 3.1% but Still Overvalued -- GF Score: 86/100
Humana Inc (HUM) Stock Down 3.1% but Still Overvalued -- GF Score: 86/100
Humana Inc (HUM) Shares Surge 3.1% -- What GF Score of 87 Tells Investors
Humana Inc (HUM) Shares Surge 3.1% -- What GF Score of 87 Tells Investors
Humana (HUM) Surges 129% in Q2 Amid Medicare Advantage Payment Proposals
Humana (HUM) Surges 129% in Q2 Amid Medicare Advantage Payment Proposals
The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 m...
Swedish care provider Ambea makes recommended $304 million offer for Humana
Swedish care provider Ambea said on Monday it had made a recommended public offer for peer Humana , valuing the company at about 2.96 billion Swedish crowns ($304.13 million).
A Look at Humana Inc (HUM) After 4.0% Gain -- GF Value $362.88 vs Price $376.00
A Look at Humana Inc (HUM) After 4.0% Gain -- GF Value $362.88 vs Price $376.00
Humana (HUM) Has a Medicare Advantage Recovery Setup That Looks Bigger Than the Medical-Cost Scare
The market has been treating Humana as a structurally broken managed care company. The stock has been under sustained pressure... The post Humana (HUM) Has a Medicare Advantage Recovery Setup That Loo...
HUM Ex-Dividend Reminder - 6/26/26
Looking at the universe of stocks we cover at Dividend Channel, on 6/26/26, Humana Inc. (Symbol: HUM) will trade ex-dividend, for its quarterly dividend of $0.885, payable on 7/31/26. As a percentage ...
Humana Inc. (NYSE: HUM) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Regarding Healthcare Utilization Costs, Over $104 Million Insider Sales
SAN FRANCISCO, June 23, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Humana Inc. (NYSE: HUM) investors that the firm is investigating potential legal claims arising from alleged false a...
Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the second quarter 2026 (2Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Ea...
3 Stocks Doing the Heavy Lifting in Healthcare's Rebound
Until recently, it had been a lackluster year for the healthcare sector. From high medical utilization squeezing insurers to structural cost pressures and valuation hangovers, medical stocks stocks ha...
The Big 3: HUM, BAC, MSFT
@Theotrade's Don Kaufman walks us through today's Big 3 and offers example options trades for his picks. He points to Humana (HUM) as a great bearish opportunity in the weeks to come, Bank of America...
The Healthcare M&A Wave
In this week's edition of InnovationRx, we look at biotech M&A, the rise of India's Anthem Biosciences, and more. To get it in your inbox, subscribe here.
Humana (HUM) Chosen for HealthChoice Illinois Medicaid Program
Humana (HUM) Chosen for HealthChoice Illinois Medicaid Program
Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State.